Synakis
Business Services · Canada · 1-10 Employees
View Company Info for Free
Overview
Headquarters
160 College St 510, Toronto, Ontario, M5...Website
www.synakis.caRevenue
<$5 MillionIndustry
About Synakis
Synakis is a pre-clinical biotech startup focused on developing novel biomaterial-based treatments for ocular conditions such as retinal detachment and glaucoma. Their core technology, SNK-125, is an injectable hydrogel designed for ocular delivery, aimed at restoring vision and improving the lives of patients. The company is dedicated to creating biocompatible and biodegradable solutions to treat leading causes of blindness. Synakis actively participates in industry events to engage with the community and share advancements in ophthalmic therapies.Explore more
SIC Code 87,873NAICS Code 54,541Show moreSynakis Org Chart
Compare Similar Companies to Synakis
Compare insights from companies similar to Synakis, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Synakis Tech Stack
A closer look at the technologies used by Synakis
See more technologies
Top Business Services Companies
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Synakis
Sign Up For FreeTo access detailed company insights
Synakis is a pre-clinical biotech startup focused on developing novel biomaterial-based treatments for ocular conditions such as retinal detachment and glaucoma. Their core technology, SNK-125, is an injectable hydrogel designed for ocular delivery, aimed at restoring vision and improving the lives of patients. The company is dedicated to creating... Read More
